Related Experiment Videos

Three-day therapy with cephalexin for lower urinary tract infections in children

Insights

A 3-day course of cephalexin effectively treats acute lower urinary tract infections in children, offering a viable alternative to longer nitrofurantoin treatments. This approach shows comparable cure rates and low relapse incidence.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Acute lower urinary tract infections (LUTIs) are common in children.
  • Standard treatment durations for pediatric LUTIs can be lengthy.
  • Identifying shorter, effective antibiotic regimens is crucial for improving adherence and reducing potential side effects.

Purpose of the Study:

  • To compare the effectiveness of a 3-day course of cephalexin with a 10-day course of nitrofurantoin for treating acute lower urinary tract infections in children.
  • To evaluate immediate cure rates, relapse rates, and reinfection rates between the two treatment groups.
  • To assess the safety and tolerability of both antibiotic regimens.

Main Methods:

  • A prospective study involving children diagnosed with acute lower urinary tract infections.
  • Participants were randomized to receive either a 3-day course of cephalexin (25-50 mg/kg/day) or a 10-day course of nitrofurantoin (3-4 mg/kg/day).
  • Outcomes assessed included immediate cure, relapses, reinfections, and adverse events over a mean follow-up of 7-8 months.

Main Results:

  • Immediate cure rates were high for both groups: 90% for cephalexin and 96% for nitrofurantoin.
  • Relapse rates were low, with 2 cases in the cephalexin group and 1 in the nitrofurantoin group.
  • Reinfection rates during follow-up were comparable, with 2 cases in the cephalexin group and 4 in the nitrofurantoin group.
  • No significant side effects were reported for either treatment.

Conclusions:

  • A 3-day course of cephalexin is an effective and well-tolerated treatment for acute lower urinary tract infections in children.
  • Cephalexin offers a reasonable alternative to standard nitrofurantoin therapy, particularly when shorter treatment durations are preferred or other medications are less tolerated.
  • The study supports the use of shorter antibiotic courses for pediatric LUTIs, demonstrating comparable efficacy and safety profiles.

Related Concept Videos